Details

Autor(en) / Beteiligte

• Farfour, Eric
• Dortet, Laurent
• Guillard, Thomas
• Chatelain, Nicolas
• Poisson, Agathe
• Mizrahi, Assaf
• Fournier, Damien
• Bonnin, Rémy A
• Degand, Nicolas
• Morand, Philippe
• Janvier, Frédéric
• Fihman, Vincent
• Corvec, Stéphane
• Broutin, Lauranne
• Le Brun, Cécile
• Yin, Nicolas
• Héry-Arnaud, Geneviève
• Grillon, Antoine
• Bille, Emmanuelle
• Jean-Pierre, Hélène
• Amara, Marlène
• Jaureguy, Francoise
• Isnard, Christophe
• Cattoir, Vincent
• Diedrich, Tristan
• Flevin, Emilie
• Merens, Audrey
• Jacquier, Hervé
• Vasse, Marc
• On Behalf Of The Gmc Study Group

Titel

Antimicrobial Resistance in Enterobacterales Recovered from Urinary Tract Infections in France

Ist Teil von

• Pathogens (Basel), 2022-03, Vol.11 (3), p.356

Ort / Verlag

Switzerland: MDPI AG

Erscheinungsjahr

2022

Quelle

EZB Electronic Journals Library

Beschreibungen/Notizen

• In the context of increasing antimicrobial resistance in Enterobacterales, the management of these UTIs has become challenging. We retrospectively assess the prevalence of antimicrobial resistance in Enterobacterales isolates recovered from urinary tract samples in France, between 1 September 2017, to 31 August 2018. Twenty-six French clinical laboratories provided the susceptibility of 134,162 Enterobacterales isolates to 17 antimicrobials. The most frequent species were (72.0%), (9.7%), (5.8%), and complex (2.9%). The overall rate of ESBL-producing Enterobacterales was 6.7%, and ranged from 1.0% in to 19.5% in , and from 3.1% in outpatients to 13.6% in long-term care facilities. Overall, 4.1%, 9.3% and 10.5% of the isolates were resistant to cefoxitin, temocillin and pivmecillinam. Cotrimoxazole was the less active compound with 23.4% resistance. Conversely, 4.4%, 12.9%, and 14.3% of the strains were resistant to fosfomycin, nitrofurantoin, and ciprofloxacin. However, less than 1% of was resistant to fosfomycin and nitrofurantoin. We identified several trends in antibiotics resistances among Enterobacterales isolates recovered from the urinary tract samples in France. Carbapenem-sparing drugs, such as temocillin, mecillinam, fosfomycin, cefoxitin, and nitrofurantoin, remained highly active, including towards ESBL-E.